证券代码：688152 证券简称：麒麟信安 公告编号：2025-052 湖南麒麟信安科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所 | | 股权登记日 | | 除权（息）日 | 新增无限售条件流通股份 | | --- | --- | --- | --- | --- | | | | | | 上市日 | | 2025/6/12 | | 2025/6/13 | | 2025/6/13 | 一、 通过转增股本方案的股东大会届次和日期 本次转增股本方案经公司2025 年 5 月 21 日的2024年年度股东大会审议通过。 二、 转增股本方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东（公 司回购专用证券账户中的股份不参与本次权益分派）。 公司存在首发战略配售股份，首发战略配售股份已全部上市流通 是否涉及差 ...

湖南麒麟信安科技股份有限公司（以下简称"公司"）于近日收到政府补助款 项合计 717.39 万元，属于与收益相关的政府补助款项。 二、补助的类型及其对公司的影响 根据《企业会计准则第 16 号-政府补助》的有关规定，公司获得的上述政府 补助属于与收益相关的政府补助。上述政府补助未经审计，具体的会计处理及对 公司 2025 年度损益的影响，最终以审计机构年度审计确认后的结果为准，敬请 投资者注意投资风险。 特此公告。 证券代码：688152 证券简称：麒麟信安 公告编号：2025-051 湖南麒麟信安科技股份有限公司 关于获得政府补助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、获得补助的基本情况 湖南麒麟信安科技股份有限公司 董事会 2025 年 6 月 4 日 ...

Group 1 - The core viewpoint highlights the positive performance of the AI sector in China, particularly through the rise of the STAR Market AI ETF, which has seen a net inflow of nearly 25 million yuan over two days [1] - The STAR Market AI ETF closely tracks the Shanghai STAR Market AI Index, which consists of 30 large-cap companies providing foundational resources, technology, and application support for AI [1] - According to the "2025 China AI Computing Power Development Assessment Report," China's intelligent computing power is expected to grow significantly, with a projected increase of 43% by 2025 compared to 2024, and potentially doubling by 2026 [1] Group 2 - CITIC Securities notes that the AI industry in China has gained sustained attention from society, driven by the breakout effect of DeepSeek, with upcoming releases of DeepSeekR2 and GPT-5 expected to continue the revaluation of the tech sector [2] - UBS highlights that international market interest in Chinese assets is increasing, supported by improved market liquidity, which enhances investor confidence and attracts long-term overseas investors [2] - The appeal of new productive forces, particularly in AI and high-end manufacturing, is driving a shift in the narrative logic of the Chinese stock market [2]

证券代码：688152 证券简称：麒麟信安 公告编号：2025-049 湖南麒麟信安科技股份有限公司 关于注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 截至本公告披露日，公司已将存放在湖南银行股份有限公司湘江新区分行（专户账号： 79010309000109954）的募集资金全部转至公司自有资金账户，用于永久补充流动资金，并办理完成该 募集资金专户的注销手续。上述募集资金专户注销后，公司与该募集资金专户开户银行、保荐机构签署 的《募集资金专户存储三方监管协议》相应终止。 特此公告。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意湖南麒麟信安科技股份有限公司首次公开发行股票注册的批复》 （证监许可【2022】2092号）核准，湖南麒麟信安科技股份有限公司（以下简称"麒麟信安"或"公司"） 向社会公开发行人民币普通股（A股）1,321.1181万股，发行价格为68.89元/股，募集资金总额为人民币 910,118,259.09元，扣除本次发行费用人民币76,927,075.33元（不含税 ...

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

证券代码：688152 证券简称：麒麟信安 公告编号：2025-050 一、获得补助的基本情况 湖南麒麟信安科技股份有限公司（以下简称"公司"）及控股子公司麒麟信安 （广东）科技有限公司于近日收到政府补助款项合计 647.99 万元，属于与收益 相关的政府补助款项。 湖南麒麟信安科技股份有限公司 关于公司及子公司获得政府补助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 特此公告。 湖南麒麟信安科技股份有限公司 董事会 2025 年 5 月 28 日 二、补助的类型及其对公司的影响 根据《企业会计准则第 16 号-政府补助》的有关规定，公司获得的上述政府 补助属于与收益相关的政府补助。上述政府补助未经审计，具体的会计处理及对 公司 2025 年度损益的影响，最终以审计机构年度审计确认后的结果为准，敬请 投资者注意投资风险。 ...

证券代码：688152 证券简称：麒麟信安 公告编号：2025-049 湖南麒麟信安科技股份有限公司 关于注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意湖南麒麟信安科技股份有限公司首次 公开发行股票注册的批复》（证监许可【2022】2092 号）核准，湖南麒麟信安 科技股份有限公司（以下简称"麒麟信安"或"公司"）向社会公开发行人民币普通 股（A 股）1,321.1181 万股，发行价格为 68.89 元/股，募集资金总额为人民币 910,118,259.09 元，扣除本次发行费用人民币 76,927,075.33 元（不含税）后，实 际募集资金净额为人民币 833,191,183.76 元。上述募集资金已于 2022 年 10 月 20 日全部到位，天职国际会计师事务所（特殊普通合伙）对本次发行募集资金到账 情况进行了审验，并出具了天职业字[2022]41533 号《验资报告》。 二、募集资金管理情况 公司于 2025 年 2 月 14 ...

麒麟信安公告，公司及控股子公司麒麟信安(广东)科技有限公司近日收到政府补助款项合计647.99万 元，属于与收益相关的政府补助款项。上述政府补助未经审计，具体的会计处理及对公司2025年度损益 的影响，最终以审计机构年度审计确认后的结果为准。 ...

Core Viewpoint - 麒麟信安 has shown significant growth in 2024, with a revenue of 286 million yuan, marking a 75.24% year-on-year increase, and a net profit of 7.94 million yuan, successfully turning a profit [1] Group 1: Financial Performance - In 2024, the company achieved a revenue of 286 million yuan, a 75.24% increase compared to the previous year [1] - The net profit for 2024 was 7.94 million yuan, indicating a successful turnaround from previous losses [1] - The revenue from the power industry reached 139 million yuan, growing by 75.91% year-on-year, accounting for nearly 50% of total revenue [1] Group 2: Business Development - The company’s defense business is expected to accelerate by 2025 after a period of stagnation [1] - The growth in the power sector is attributed to the company's long-term investments and the introduction of new products, including cloud computing and information security solutions [2] - The company is actively expanding into other sectors, with revenue growth outside of power and special industries noted in the previous year [2] Group 3: Future Outlook - The State Grid is projected to invest over 650 billion yuan in 2025, which is expected to increase demand for domestic operating systems, cloud computing, and commercial password products [2] - The company is enhancing its national network layout to better penetrate various sectors, including government, education, healthcare, and transportation [2] - The company plans to launch an intelligent operation system for its cloud platform, integrating AI and machine learning technologies [3]

湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 致：湖南麒麟信安科技股份有限公司 湖南启元律师事务所接受湖南麒麟信安科技股份有限公司（以下简称"公司"） 的委托，指派本所律师出席了公司 2024 年年度股东大会（以下简称"本次股东大 会"），对本次股东大会的召集和召开程序、出席会议人员及召集人的资格、表决 程序和表决结果的合法有效性进行现场律师见证，并发表本法律意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》 （以下简称"《证券法》"）、 《上市公司股东会规则》 （以下简 称"《股东会规则》"）等法律、法规和规范性文件以及《湖南麒麟信安科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本法律意见书。 法律意见书 二零二五年五月 本所律师出具本法律意见书基于公司已作出如下承诺：所有提供给本所律师 的文件的正本以及经本所律师查验与正本保持一致的副本均为真实、完整、准确。 为出具本法律意见书，本所依法审核了公司提供的下列资料： 会 有关的通知等公告事项； 书等； 登记记录及相关资料； 鉴此 ...